Synlab , the leading provider of medical
diagnostic services in Europe, yesterday announced the acquisition of
a majority stake in Pathcare Nigeria Limited, the largest private
medical laboratory group in Nigeria. With this step, Synlab enters
the private medical laboratory market in Nigeria.
PathCare Nigeria is a market leader in
Nigeria in the field of human laboratory diagnostics, with a special
focus on public private partnerships. Its strong market position is
based on its high-quality service, the breadth of its test portfolio,
and its nationwide network.
The transaction with Synlab allows
PathCare Nigeria the ability to offer its Nigerian customers an
extended portfolio of specialised tests being sourced from the Synlab network. The company will benefit from the technological advancements
and comprehensive cost-effective solutions to enhance the local
business with hospitals and other customers. With more than 200
employees, PathCare Nigeria operates six laboratories and 21 blood
collection points across Nigeria and is engaged in a public private
partnership with the leading public hospital in Lagos, the largest
city in Africa.
Thomas Degott, CEO of SYNLAB Emerging
Markets, commented: “Nigeria has a population of about 186 million,
but a large proportion of the population does not yet have access to
modern medical diagnostics. PathCare Nigeria’s customers will
benefit from an enhanced test portfolio drawing from the breadth and
depth of SYNLAB’s international expertise.”
Dr. Pamela Ajayi, Managing Director,
PathCare Nigeria, commented – We are very pleased to be joining the
SYNLAB group. There will be huge advantages to having the European
Diagnostic Leader in Nigeria, bringing the most modern technological
advancements in the field within the reach of every Nigerian.
PathCare Nigeria will continue to push the boundaries. We also expect
this investment to have a positive impact on healthcare development
in the Country.”
No comments:
Post a Comment